Literature DB >> 10080180

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.

G Bonne1, M R Di Barletta, S Varnous, H M Bécane, E H Hammouda, L Merlini, F Muntoni, C R Greenberg, F Gary, J A Urtizberea, D Duboc, M Fardeau, D Toniolo, K Schwartz.   

Abstract

Emery-Dreifuss muscular dystrophy (EDMD) is characterized by early contractures of elbows and Achilles tendons, slowly progressive muscle wasting and weakness, and a cardiomyopathy with conduction blocks which is life-threatening. Two modes of inheritance exist, X-linked (OMIM 310300) and autosomal dominant (EDMD-AD; OMIM 181350). EDMD-AD is clinically identical to the X-linked forms of the disease. Mutations in EMD, the gene encoding emerin, are responsible for the X-linked form. We have mapped the locus for EDMD-AD to an 8-cM interval on chromosome 1q11-q23 in a large French pedigree, and found that the EMD phenotype in four other small families was potentially linked to this locus. This region contains the lamin A/C gene (LMNA), a candidate gene encoding two proteins of the nuclear lamina, lamins A and C, produced by alternative splicing. We identified four mutations in LMNA that co-segregate with the disease phenotype in the five families: one nonsense mutation and three missense mutations. These results are the first identification of mutations in a component of the nuclear lamina as a cause of inherited muscle disorder. Together with mutations in EMD (refs 5,6), they underscore the potential importance of the nuclear envelope components in the pathogenesis of neuromuscular disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080180     DOI: 10.1038/6799

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  340 in total

Review 1.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.

Authors:  J Schönberger; C E Seidman
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

Review 2.  The inner nuclear membrane: simple, or very complex?

Authors:  S D Georgatos
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

Review 3.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

4.  LINCing lamin B2 to neuronal migration: growing evidence for cell-specific roles of B-type lamins.

Authors:  Catherine Coffinier; Loren G Fong; Stephen G Young
Journal:  Nucleus       Date:  2010 Sep-Oct       Impact factor: 4.197

5.  A plasma membrane wound proteome: reversible externalization of intracellular proteins following reparable mechanical damage.

Authors:  Ronald L Mellgren
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

Review 6.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

7.  Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy.

Authors:  B Granger; L Gueneau; V Drouin-Garraud; V Pedergnana; F Gagnon; R Ben Yaou; S Tezenas du Montcel; G Bonne
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

Review 8.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

9.  Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.

Authors:  V Cenni; P Sabatelli; E Mattioli; S Marmiroli; C Capanni; A Ognibene; S Squarzoni; N M Maraldi; G Bonne; M Columbaro; L Merlini; G Lattanzi
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

Review 10.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.